{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:32Z","timestamp":1740144152760,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-023-00605-1","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:02:22Z","timestamp":1698656542000},"page":"551-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations"],"prefix":"10.1007","volume":"30","author":[{"given":"Matteo","family":"Landolfo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1846-7819","authenticated-orcid":false,"given":"Francesco","family":"Spannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Gezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sarzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"issue":"25","key":"605_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"605_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"RM Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987\u20131003.","journal-title":"Eur Heart J"},{"issue":"25","key":"605_CR3","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 risk prediction algorithms","year":"2021","unstructured":"SCORE2 risk prediction algorithms. new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"key":"605_CR4","doi-asserted-by":"publisher","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023 Jun 21. https:\/\/doi.org\/10.1097\/HJH.0000000000003480. Online ahead of print.","DOI":"10.1097\/HJH.0000000000003480"},{"key":"605_CR5","doi-asserted-by":"crossref","unstructured":"Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, et al. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients. Lancet 2023 Jun 17;401(10393):2041-2050.","DOI":"10.1016\/S0140-6736(23)00733-X"},{"issue":"32","key":"605_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"key":"605_CR7","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"605_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cca.2014.02.018","volume":"431","author":"M Nakamura","year":"2014","unstructured":"Nakamura M, Kayamori Y, Iso H, Kitamura A, Kiyama M, Koyama I, et al. LDL cholesterol performance of beta quantification reference measurement procedure. Clin Chim Acta. 2014;431:288\u201393.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"605_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"10","key":"605_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28817","volume":"4","author":"A Sajja","year":"2021","unstructured":"Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, et al. Comparison of methods to estimate low-density lipoprotein cholesterol in patients with high triglyceride levels. JAMA Netw Open. 2021;4(10): e2128817.","journal-title":"JAMA Netw Open"},{"key":"605_CR11","doi-asserted-by":"publisher","unstructured":"Bolat S, Ert\u00fcrk Zarars\u0131z G, Do\u011fan K, Kochan N, Yerlita\u015f SI, Cephe A, et al. Concordance of LDL-C estimating equations with direct enzymatic measurement in diabetic and prediabetic subjects. J Clin Med\n. 2023 May 20;12(10):3570. https:\/\/doi.org\/10.3390\/jcm12103570.","DOI":"10.3390\/jcm12103570"},{"issue":"19","key":"605_CR12","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532","volume":"310","author":"SS Martin","year":"2013","unstructured":"Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310(19):2061\u20138.","journal-title":"JAMA"},{"issue":"8","key":"605_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamacardio.2018.1533","volume":"3","author":"SS Martin","year":"2018","unstructured":"Martin SS, Giugliano RP, Murphy SA, Wasserman SM, Stein EA, Ce\u0161ka R, et al. Comparison of low-density lipoprotein cholesterol assessment by martin\/hopkins estimation, friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER Trial. JAMA Cardiol. 2018;3(8):749\u201353.","journal-title":"JAMA Cardiol."},{"issue":"5","key":"605_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540\u20138.","journal-title":"JAMA Cardiol."},{"key":"605_CR15","doi-asserted-by":"publisher","unstructured":"Ginsberg HN, Rosenson RS, Hovingh GK, Letierce A, Samuel R, Poulouin Y, et al. LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials. J Lipid Res\n. 2022 Jan;63(1):100148. https:\/\/doi.org\/10.1016\/j.jlr.2021.100148. Epub 2021 Nov 11.","DOI":"10.1016\/j.jlr.2021.100148"},{"issue":"1","key":"605_CR16","volume":"32","author":"PJ Briers","year":"2022","unstructured":"Briers PJ, Langlois MR. Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol. Biochem Med (Zagreb). 2022;32(1): 010704.","journal-title":"Biochem Med (Zagreb)."},{"issue":"5","key":"605_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40292-020-00396-9","volume":"27","author":"F Giulietti","year":"2020","unstructured":"Giulietti F, Filipponi A, Rosettani G, Giordano P, Iacoacci C, Spannella F, et al. Pharmacological approach to smoking cessation: an updated review for daily clinical practice. High Blood Press Cardiovasc Prev. 2020;27(5):349\u201362.","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"5","key":"605_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MBP.0000000000000135","volume":"20","author":"S Omboni","year":"2015","unstructured":"Omboni S, Palatini P, Parati G. Standards for ambulatory blood pressure monitoring clinical reporting in daily practice: recommendations from the Italian Society of Hypertension. Blood Press Monit. 2015;20(5):241\u20134.","journal-title":"Blood Press Monit"},{"issue":"33","key":"605_CR19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"1","key":"605_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41(1):111\u201388.","journal-title":"Eur Heart J"},{"issue":"34","key":"605_CR21","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"issue":"7","key":"605_CR22","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","volume":"39","author":"GS Stergiou","year":"2021","unstructured":"Stergiou GS, Palatini P, Parati G, O\u2019Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293\u2013302.","journal-title":"J Hypertens"},{"issue":"2","key":"605_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40292-021-00503-4","volume":"29","author":"M Volpe","year":"2022","unstructured":"Volpe M, Gallo G, Modena MG, Ferri C, Desideri G, Tocci G. Updated recommendations on cardiovascular prevention in 2022: an executive document of the italian society of cardiovascular prevention. High Blood Press Cardiovasc Prev. 2022;29(2):91\u2013102.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"605_CR24","doi-asserted-by":"publisher","unstructured":"Boskovic N, Giga V, Djordjevic-Dikic A, Beleslin B, Stojkovic S, Nedeljkovic I, et al. Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk european population. European Heart Journal, Volume 43, Issue Supplement_2, October 2022, ehac544.2281, https:\/\/doi.org\/10.1093\/eurheartj\/ehac544.2281","DOI":"10.1093\/eurheartj\/ehac544.2281"},{"key":"605_CR25","doi-asserted-by":"publisher","unstructured":"Csenteri O, Jancs\u00f3 Z, Sz\u00f6ll\u00f6si GJ, Andr\u00e9ka P, Vajer P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart\n. 2022 Nov;9(2):e002087. https:\/\/doi.org\/10.1136\/openhrt-2022-002087.","DOI":"10.1136\/openhrt-2022-002087"},{"issue":"2","key":"605_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40292-023-00568-3","volume":"30","author":"R Del Pinto","year":"2023","unstructured":"Del Pinto R, Giua C, Keber E, Grippa E, Tilotta M, Ferri C. Impact of 2021 ESC Guidelines for cardiovascular disease prevention on hypertensive patients risk: secondary analysis of save your heart study. High Blood Press Cardiovasc Prev. 2023;30(2):167\u201373.","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"6","key":"605_CR27","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12325-019-00941-6","volume":"36","author":"F Spannella","year":"2019","unstructured":"Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded \u201cDouble-Trouble\u201d lipid profile in overweight\/obese. Adv Ther. 2019;36(6):1426\u201337.","journal-title":"Adv Ther"},{"issue":"3","key":"605_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40292-022-00507-8","volume":"29","author":"C Borghi","year":"2022","unstructured":"Borghi C, Fogacci F, Agnoletti D, Cicero AFG. Hypertension and dyslipidemia combined therapeutic approaches. High Blood Press Cardiovasc Prev. 2022;29(3):221\u201330.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"605_CR29","doi-asserted-by":"publisher","first-page":"204062232211027","DOI":"10.1177\/20406223221102754","volume":"13","author":"R Sarzani","year":"2022","unstructured":"Sarzani R, Laureti G, Gezzi A, Spannella F, Giulietti F. Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient. Ther Adv Chronic Dis. 2022;13:20406223221102750.","journal-title":"Ther Adv Chronic Dis."},{"issue":"3","key":"605_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jcp-2022-208480","volume":"76","author":"J Martins","year":"2023","unstructured":"Martins J, Steyn N, Rossouw HM, Pillay TS. Best practice for LDL-cholesterol: when and how to calculate. J Clin Pathol. 2023;76(3):145\u201352.","journal-title":"J Clin Pathol"},{"issue":"10263","key":"605_CR31","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","volume":"396","author":"MB Mortensen","year":"2020","unstructured":"Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644\u201352.","journal-title":"Lancet"},{"issue":"10263","key":"605_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","volume":"396","author":"B Gencer","year":"2020","unstructured":"Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, et al. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020;396(10263):1637\u201343.","journal-title":"Lancet"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-023-00605-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-023-00605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T03:21:29Z","timestamp":1702610489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-023-00605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1007\/s40292-023-00605-1","relation":{},"ISSN":["1179-1985"],"issn-type":[{"type":"electronic","value":"1179-1985"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients included in the study provided informed consent, and the local ethical committee (INRCA IRCCS of Ancona, Italy) approved the investigation according to the declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets used and analysed during the current study are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and Materials"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This research was funded by \"Politecnica delle Marche\" University (Ricerca di Ateneo to Prof. Riccardo Sarzani). This research received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"ML made the analyses. ML and MA wrote the manuscript. ML elaborated tables and figures. FS, MA, AG, FG, and RS planned and supervised the whole study and revised the manuscript. ML and MA should both be considered as first authors. All the authors contributed equally to the data collection and preparation of the dataset.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author's Contributions"}}]}}